Video

CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cell Immunotherapy For Adult B Cell Malignancies

Name: CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cell Immunotherapy For Adult B Cell Malignancies
Uploaded: 2019-06-10T00:00:00+00:00
Description: Cameron J. Turtle, MD, PhD, covers the background and rationale for CD19 CAR-T cell therapy, clinical responses and approaches to mitigate toxicity.

Overview

Cameron J. Turtle, MD, PhD, covers the background and rationale for CD19 CAR-T cell therapy, clinical responses and approaches to mitigate toxicity.

Created by

Related Presenters

Cameron Turtle, MD, PhD

Biography Cameron Turtle, M.D., Ph.D., is a hematology oncologist at SCCA, a UW assistant professor of Oncology and Medicine and a research associate at Fred Hutchinson Cancer Research Center. Patients with hematologic malignancies are ...

View full profile

Related Videos

Video

Progress in Prostate Cancer Appears to Slow

Over the last 25 years, Dr. Daniel Lin says, there has been a 25-30% decrease in deaths from prostate cancer.

Video

Robotic Surgery Leads to Faster Recovery Time

James Park, MD, explains the benefits of robotic surgery and how minimally invasive procedures allow patients a quicker recovery period.

Video

Treatment In The Management Of Diffuse Large B-Cell Lymphoma And Follicular Lymphoma

Ryan Lynch, MD, on diffuse large B-cell lymphoma and follicular lymphoma: integrating components of IPI score with pathology information to create an evidence-based treatment approach and assessing which patients require systemic and/or local therapy.

Video

Breast Cancer Screening and Benign Breast Disease

Meghan Flanagan, MD, presents on benign breast disease, which is a symptomatic breast condition with physical signs and symptoms that go beyond expected physiologic changes.